TOUJEO SOLOSTAR

Google image searchProduct monograph

Active ingredient

insulin glargine, 300 UNIT/ML

DIN: 02441829

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 1.5ML (450 IU) PREFILLED PEN

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 15-JUL-2015

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AE — Insulins and analogues for injection, long-acting (ATC, ATC/DDD)
• A10AE04 — INSULIN GLARGINE (ATC/DDD)

Reference brand drug: Lantus, Basaglar, Semglee, Toujeo

External Links for Toujeo Solostar

Search on Google

• Toujeo Solostar side effects
• Toujeo Solostar dosage
• insulin glargine side effects
• insulin glargine dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find toujeo solostar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.